Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 9/20 | 0.33 |
| ▸ | PPARA | Q07869 | 9/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20150606 | 0.94 | MCL1 (0.33) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL20150598 | 0.94 | PPARG (0.34) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL20150614 | 0.93 | ENPP3 (0.32) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL20150623 | 0.93 | CA12 (0.34) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL20150615 | 0.92 | CA12 (0.34) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL20150625 | 0.91 | CA12 (0.35) | PPARGPPARAMCL1ACMSD | |
| SCHEMBL20150597 | 0.91 | CA12 (0.34) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL20150629 | 0.90 | — | — | |
| SCHEMBL20150630 | 0.90 | — | — | |
| SCHEMBL20150631 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10550134-B2 | Heterocyclic compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-04 | — | — | US | disclosed |
| US-20180134732-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
| US-20180134732-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10550134-B2 | Heterocyclic compound and organic electroluminescence device including the same | ODC1, KCNC1, KCNH1 | PPARG 2162/4885PPARA 2427/4885CYP2C9 42/4885 |
| US-20180134732-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | ODC1, KCNC1, KCNH1 | PPARG 2162/4885PPARA 2427/4885CYP2C9 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.